Conference Description
The Metals in Medicine GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The clinical successes of the platinum-based anticancer drugs, technetium-based radiopharmaceuticals, and gadolinium-based MRI contrast agents have boosted the interdisciplinary research area of metals in medicine, which is rapidly evolving and affording new highly effective and selective drug candidates with great translational potential. The main goal of the 2026 Metals in Medicine GRC is to showcase impactful discoveries in both basic and translational research, while fostering a cross-disciplinary supportive community of scientists and clinicians that provides a valuable training environment for the next generation of researchers. This conference aims to advance knowledge in the mode of action and use of metallodrugs to treat and diagnose human diseases. Sessions will highlight the latest findings on understanding the modes of action and activation of metal-based drugs, optimization of drug delivery strategies, the use of such compounds to treat neglected tropical diseases and cancer, radionuclide-based therapeutics and diagnostics, and inorganic chemistry-based imaging modalities. We have included a session on the clinical translation of metal-based drugs. In addition, this GRC will advance the knowledge on the effects of metal ions on human diseases with sessions on the latest advances in metal ion regulation and/or dysregulation in human disease, and in metalloneurochemistry. This GRC will provide a multidisciplinary, engaging, and supportive environment for idea exchanges between researchers at all professional development stages. Several program components are designed to feature early-career investigators.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by September 24, 2025. Please check back for updates.
